Lupus Science & Medicine

Papers
(The H4-Index of Lupus Science & Medicine is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
2021 DORIS definition of remission in SLE: final recommendations from an international task force140
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials59
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies39
Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to ac37
Living with systemic lupus erythematosus in 2020: a European patient survey36
Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review31
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis30
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria30
SARS-CoV-2 vaccines in patients with SLE29
Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data28
Phenotypical changes and clinical significance of CD4+/CD8+T cells in SLE24
Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis24
Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries24
Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study23
Herpes zoster in SLE: prevalence, incidence and risk factors23
Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway23
Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis22
Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–201522
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus21
LLDAS is an attainable treat-to-target goal in childhood-onset SLE21
Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis21
0.12010598182678